Alnylam Pharmaceuticals Inc (ALNY)
249.65
-1.35
(-0.54%)
USD |
NASDAQ |
Feb 21, 15:53
Alnylam Pharmaceuticals Market Cap: 32.32B for Feb. 21, 2025
View 4,000+ Financial Data Types:
Add
Browse
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Pfizer Inc | 149.44B |
BridgeBio Pharma Inc | 6.966B |
Biomarin Pharmaceutical Inc | 12.93B |
Regeneron Pharmaceuticals Inc | 76.72B |
Sarepta Therapeutics Inc | 10.15B |
Market Cap Related Metrics
PS Ratio | 14.17 |
Price to Book Value | 481.74 |
Price | 249.65 |
Earnings Yield | -0.87% |